Detection of inflammatory bowel disease by proton magnetic resonance spectroscopy (1H MRS) using an animal model

Journal of Inflammation

Volumn 4, Issue , 2007, Pages

  Varma, Sonal ^a,b   Bird, Ranjana ^c   Eskin, Michael ^b   Dolenko, Brion ^a   Raju, Jayadev ^c   Bezabeh, Tedros ^a,b  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c UNIVERSITY OF WATERLOO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARRAGEENAN; CREATINE; FATTY ACID; GLYCEROL; LIPID; PHOSPHATIDYLCHOLINE;

ALGORITHM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; COLON BIOPSY; COLON MUCOSA; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENTERITIS; EX VIVO STUDY; HISTOLOGY; MALE; METABOLITE; MULTIVARIATE ANALYSIS; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; RADIODIAGNOSIS; RAT; STAINING;

ANIMALIA; RATTUS;

EID: 38349109358     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-4-24     Document Type: Article

References (33)

1. Recent trends in the epidemiology of inflammatory bowel diseases: Up or down. PL Lakatos, World J Gastroenterol 2006 12 6102 6108 17036379
2. The epidemiology and the pathogenesis of inflammatory bowel disease. K Karlinger T Gyorke E Mako A Mester Z Tarjan, Eur J Radiol 2000 35 154 167 10.1016/S0720-048X(00)00238-2 11000558
3. Colorectal carcinoma and inflammatory bowel disease. J Eaden, Aliment Pharmacol Ther 2004 20 24 30 10.1111/j.1365-2036.2004.02046.x 15352890
4. Is nutrition an aetiological factor for inflammatory bowel disease. KD Cashman F Shanahan, Eur J Gastroenterol Hepatol 2003 15 607 613 10.1097/00042737-200306000-00005 12840670
5. Effect of fish oil enriched enteral diet on inflammatory bowel disease tissues in organ culture: differential effects on ulcerative colitis and Crohn's disease. D Meister S Ghosh, World J Gastroenterol 2005 11 7466 7472 16437718
6. Fish oil fatty acid supplementation in active ulcerative colitis: a double-blind, placebo-controlled, crossover study. A Aslan G Triadafilopoulos, Am J Gastroenterol 1992 87 432 437 1553930
7. Experimental colitis in animal models. HS Kim A Berstad, Scand J Gastroenterol 1992 27 529 537 10.3109/00365529209000116 1641579
8. Development of the early mucosal lesions in experimental inflammatory bowel disease - implications for pathogenesis. TN Moyana J Xiang Y Qi J Kalra, Exp Mol Pathol 1994 60 119 129 10.1006/exmp.1994.1011 8070540
9. Effects of lambda-carrageenan induced experimental enterocolitis on splenocyte function and nitric oxide production. VE Pricolo SM Madhere SD Finkelstein JS Reichner, J Surg Res 1996 66 6 11 10.1006/jsre.1996.0364 8954824
10. The use of 1-H magnetic resonance spectroscopy in inflammatory bowel diseases: distinguishing ulcerative colitis from Crohn's disease. T Bezabeh RL Somorjai IC Smith AE Nikulin B Dolenko CN Bernstein, Am J Gastroenterol 2001 96 442 448 10.1111/j.1572-0241.2001.03523.x 11232688
11. Contribution of the MR spectroscopic imaging in the diagnosis of prostate cancer in the peripheral zone. E Casciani E Polettini L Bertini G Masselli P Emiliozzi M Amini V Pansadoro GF Gualdi, Abdom Imaging 2007 17294342
12. Magnetic resonance spectroscopy in the monitoring of multiple sclerosis. PA Narayana, J Neuroimaging 2005 Suppl 15 46 57 10.1177/1051228405284200
13. Proton MR spectroscopy in the diagnosis of early-stage subacute sclerosing panencephalitis. M Teksam B Cakir AM Agildere, Diagn Interv Radiol 2006 12 61 63 16752349
14. The classification of benign and malignant human prostate tissue by multivariate analysis of 1H magnetic resonance spectra. P Hahn IC Smith L Leboldus C Littman RL Somorjai T Bezabeh, Cancer Res 1997 57 3398 3401 9270004
15. Opinion: understanding 'global' systems biology: metabonomics and the continuum of metabolism. JK Nicholson ID Wilson, Nat Rev Drug Discov 2003 2 668 676 10.1038/nrd1157 12904817
16. 1H MR visible lipids in colon tissue from normal and carcinogen-treated rats. KM Briere AC Kuesel RP Bird IC Smith, NMR Biomed 1995 8 33 40 10.1002/nbm.1940080108 7547183
17. A simple procedure for obtaining high-quality NMR spectra of semiquantitative value from small tissue specimens: cervical biopsies. AC Kuesel T Kroft JK Saunders M Prefontaine N Mikhael IC Smith, Magn Reson Med 1992 27 349 355 10.1002/mrm.1910270215 1461119
18. Near-optimal region selection for feature space reduction: novel preprocessing methods for classifying MR spectra. AE Nikulin B Dolenko T Bezabeh RL Somorjai, NMR Biomed 1998 11 209 217 10.1002/(SICI)1099-1492(199806/08)11:4/ 5<209::AID-NBM510>3.0.CO;2-5 9719575
19. A data-driven, flexible machine learning strategy for the classification of biomedical data. RL Somorjai M Alexander R Baumgartner S Booth C Bowman A Demko B Dolenko M Mandelzweig AE Nikulin N Pizzi N Pranckeviciene R Summers P Zhilkin, Computational Biology, Artificial Intelligence Methods and Tools for Systems Biology Boston: Kluwer Academic Publishers, Azuaje F, Dubitsky W, 2004 5 67 85
20. Patchiness of mucosal inflammation in treated ulcerative colitis: a prospective study. CN Bernstein F Shanahan PA Anton WM Weinstein, Gastrointest Endosc 1995 42 232 237 10.1016/S0016-5107(95)70097-8 7498688
21. Effects of Probiotic Lactobacillus Paracasei Treatment on the Host Gut Tissue Metabolic Profiles Probed via Magic-Angle-Spinning NMR Spectroscopy. FP Martin Y Wang N Sprenger E Holmes JC Lindon S Kochhar JK Nicholson, J Proteome Res 2007
22. Physical properties and functional roles of lipids in membranes. PR Cullis MJ Hope, Biochemistry of lipids, lipoproteins and membranes Amsterdam: Elsevier Science publishers, Vance DE, 1992 1 41
23. The phospholipid composition of mammalian tissue. DA White, Form and function of phospholipids Amsterdam. Elsevier Scienctific publishing Co, Ansell GB, Hawthorne JN, Dawson RMC, 1973 441 482
24. Quantification of distinct molecular species of platelet activating factor in ulcerative colitis. E Thyssen J Turk A Bohrer WF Stenson, Lipids 1996 31 255 259 10.1007/BF02637086
25. Platelet activating factor in stool from patients with ulcerative colitis and Crohn's disease. M Hocke L Richter H Bosseckert K Eitner, Hepatogastroenterology 1999 46 2333 2337 10521992
26. Chemical shift imaging of human colorectal tissue (ex vivo). D Ende A Rutter P Russell CE Mountford, NMR Biomed 1996 9 179 183 10.1002/(SICI)1099- 1492(199606)9:4<179::AID-NBM407>3.0.CO;2-N 9015805
27. Immunohistochemical localization of creatinkinase isoenzymes in human tissue. E Jockers-Wretou W Giebel G Pfleiderer, Histochemistry 1977 54 83 95 10.1007/BF00493332 334711
28. An analysis of creatine phosphokinase in the mucosa and the muscularis of the gastrointestinal tract. GM Graeber PJ Cafferty RE Wolf JW Harmon, J Surg Res 1984 37 376 382 10.1016/0022-4804(84)90203-8 6333551
29. NMR lipid profiles of cells, tissues, and body fluids: proton NMR analysis of human erythrocyte lipids. RK Adosraku GT Choi V Constantinou-Kokotos MM Anderson WA Gibbons, J Lipid Res 1994 35 1925 1931 7868971
30. Dietary fat: exogenous determination of membrane structure and cell function. MT Clandinin S Cheema CJ Field ML Garg J Venkatraman TR Clandinin, FASEB J 1991 5 2761 2769 1916101
31. Omega-3 fatty acids in inflammation and autoimmune diseases. AP Simopoulos, J Am Coll Nutr 2002 21 495 505 12480795
32. Increased arachidonic acid composition of phospholipids in colonic mucosa from patients with active ulcerative colitis. T Nishida H Miwa A Shigematsu M Yamamoto M Iida M Fujishima, Gut 1987 28 1002 1007 3117625 10.1136/gut.28.8.1002
33. Changes in plasma and colonic mucosa fatty acid profiles in rats with ulcerative colitis induced by trinitrobenzene sulfonic acid. N Nieto MD Giron MD Suarez A Gil, Dig Dis Sci 1998 43 2688 2695 10.1023/A:1026607428716 9881501